Overwhelming evidence demonstrated that serum HER2 level hasthe potential value to predict tumor HER2 status as detected by IHC [11], [12] and is associatedwith tumor progression, recurrence and poor prognosis [13], [14], [15]. Here, ERBB2 is linked to neoplasm.